Latest available resultsQuarter ended June 30, 202610-Q · July 31, 2026
Filed with the SECMETTLER TOLEDO INTERNATIONAL INC/
MTDHealthcare
Next reportNovember 4, 2026after close · Analyst forecast 12.218 $/share
Revenue
$1.03B
▲ +4.5% vs prior year% YoY
Net income
$232.90M
▲ +15.1% vs prior year% YoY
EPS
11.55$
▲ +18.3% vs prior year% YoY
Net margin
22.7%
▲ +2.1 percentage points vs prior year pp YoY
Revenue▲ +4.5 %
Margins (% of revenue)GrossOperating N/ANet
Net income▲ +15.1 %
EPS▲ +18.3 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.03B | |
| Gross profit | $650.22M | 63.3 % |
| Operating income | — | never filed |
| Net income | $232.90M | 22.7 % |
| R&D | $52.99M | 5.2 % |
| EPS (diluted) | 11.55 $ | |
| Balance sheet | ||
| Assets | $3.67B | |
| Liabilities | $3.66B | |
| Equity | $12.82M | |
| Cash | $51.38M | |
| Capital | ||
| Shares outstanding | — | |
| Public float | — | |